Lodestar Private Asset Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-823
Closed -$220K – 238
2026
Q1
$220K Hold
823
– – 0.02% 226
2025
Q4
$206K Buy
823
+75
+10% +$19.9K 0.02% 221
2025
Q3
$215K Buy
+748
New +$200K 0.02% 219
2025
Q2
– Sell
-981
Closed -$228K – 225
2025
Q1
$228K Hold
981
– – 0.03% 203
2024
Q4
$225K Hold
981
– – 0.03% 206
2024
Q3
$219K Buy
+981
New +$216K 0.03% 208
2024
Q2
– Sell
-981
Closed -$214K – 212
2024
Q1
$214K Hold
981
– – 0.03% 204
2023
Q4
$223K Buy
+981
New +$206K 0.03% 190
2023
Q3
– Sell
-1,142
Closed -$237K – 199
2023
Q2
$237K Hold
1,142
– – 0.04% 180
2023
Q1
$225K Hold
1,142
– – 0.04% 181
2022
Q4
$231K Buy
+1,142
New +$223K 0.04% 178

Other funds holding LH

Lodestar Private Asset Management's LH Position: Q2 2026 in Review

Lodestar Private Asset Management sold out of Labcorp (LH) in Q2 2026, closing a stake of 823 shares — an estimated $220K sold.

Lodestar Private Asset Management first reported a position in LH in Q4 2022 and held it in 11 quarters. The position peaked at $237K in Q2 2023. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Lodestar Private Asset Management reported no remaining Labcorp position as of Q2 2026 after selling out during the quarter.
  • Lodestar Private Asset Management sold 823 Labcorp shares in Q2 2026, an estimated $220K.
  • Lodestar Private Asset Management first reported a position in Labcorp in Q4 2022 and held it in 11 quarters.
  • Lodestar Private Asset Management's Labcorp position peaked at $237K in Q2 2023.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Lodestar Private Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.